Chapel Hill, NC, United States of America

Elena Dukhovlinova

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The General Hospital Corporation, The University of North Carolina at Chapel Hill. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elena Dukhovlinova. Retrieved from https://idiyas.com/inventor/elena-dukhovlinova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elena Dukhovlinova: Innovator in Cancer Treatment

Introduction

Elena Dukhovlinova is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods.

Latest Patents

Dukhovlinova holds a patent for "Methods and compositions for chimeric antigen receptor targeting cancer cells." This invention provides a chimeric antigen receptor (CAR) that recognizes CSPG4, along with methods of use in the treatment of various diseases and disorders. Her work is pivotal in advancing cancer therapies.

Career Highlights

Throughout her career, Dukhovlinova has been associated with esteemed institutions such as the University of North Carolina at Chapel Hill and The General Hospital Corporation. Her research has focused on developing novel approaches to combat cancer, showcasing her dedication to improving patient outcomes.

Collaborations

Dukhovlinova has collaborated with notable professionals in her field, including Gianpietro Dotti and Soldano Ferrone. These partnerships have enhanced her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Elena Dukhovlinova's innovative work in cancer treatment exemplifies her commitment to scientific advancement. Her contributions through patents and collaborations continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…